Chen, R., Zhao, J., Zhang, X., Lou, N., Chen, H., Yang, X., . . . Yang, J. (2018). Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression. BMC.
Citación estilo ChicagoChen, Rui-Lian, et al. Crizotinib in Advanced Non-small-cell Lung Cancer With Concomitant ALK Rearrangement and C-Met Overexpression. BMC, 2018.
Cita MLAChen, Rui-Lian, et al. Crizotinib in Advanced Non-small-cell Lung Cancer With Concomitant ALK Rearrangement and C-Met Overexpression. BMC, 2018.
Precaución: Estas citas no son 100% exactas.